Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

Wait 5 sec.

Concerns that well-funded Chinese companies will swoop in to grab new ideas for their own drug development are shaping an industry unaccustomed to such secrecy.